Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 1
1987 5
1988 4
1989 1
1990 2
1991 3
1992 1
1993 4
1994 1
1995 4
1996 3
1997 2
1998 1
1999 4
2000 1
2001 3
2002 3
2003 6
2004 3
2005 3
2006 4
2007 6
2008 4
2009 3
2010 7
2011 8
2012 5
2013 5
2014 3
2015 4
2016 3
2017 5
2018 8
2019 5
2020 4
2021 12
2022 22
2023 9
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Reply to Kao and Liaw.
Ochoa V, Díaz FE, Ramirez E, Fentini MC, Carobene M, Geffner J, Arruvito L, Remes Lenicov F. Ochoa V, et al. Among authors: geffner j. J Infect Dis. 2022 Aug 12;226(1):189. doi: 10.1093/infdis/jiac081. J Infect Dis. 2022. PMID: 35245935 No abstract available.
Purinergic signaling pathway in severe COVID-19.
Arruvito L, Sananez I, Seery V, Russo C, Geffner J. Arruvito L, et al. Among authors: geffner j. Curr Opin Pharmacol. 2023 Jun;70:102379. doi: 10.1016/j.coph.2023.102379. Epub 2023 Mar 23. Curr Opin Pharmacol. 2023. PMID: 37087844 Free PMC article. Review.
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, Pinto D, VanBlargan LA, De Marco A, di Iulio J, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà PE, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Snell G, Veesler D, Corti D. Cameroni E, et al. Among authors: geffner j. Nature. 2022 Feb;602(7898):664-670. doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23. Nature. 2022. PMID: 35016195 Free PMC article.
[Use of convalescent plasma for COVID-19 treatment. History and evidence].
McAllister F, Mantegazza A, Garzón F, Rotbaum V, Remondino G, Vazquez Larsson M, Geffner J, Rabinovich GA, Bover L. McAllister F, et al. Among authors: geffner j. Medicina (B Aires). 2020;80 Suppl 3:82-86. Medicina (B Aires). 2020. PMID: 32658853 Free article. Spanish. No abstract available.
Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial.
Perez Marc G, Coria LM, Ceballos A, Rodriguez JM, Lombardo ME, Bruno L, Páez Córdoba F, Fascetto Cassero CG, Salvatori M, Rios Medrano M, Fulgenzi F, Alzogaray MF, Mykietiuk A, Uriarte IL, Itcovici N, Smith Casabella T, Corral G, Bruno M, Roldán O, Núñez SA, Cahn F, Yerino GA, Bianchi A, Braem V, Christmann A, Corradetti S, Darraidou MC, Di Nunzio L, Estrada T, López Castelo R, Marchionatti C, Pitocco L, Trias Uriarte V, Wood C, Zadoff R, Bues F, Garrido RM, Montomoli E, Manenti A; Laboratorio Pablo Cassará group for ARVAC; Demaría A, Prado L, Pueblas Castro C, Saposnik L, Geffner J, Montes de Oca F, Vega JC, Fló J, Bonvehí P, Cassará J, Pasquevich KA, Cassataro J. Perez Marc G, et al. Among authors: geffner j. Vaccine. 2025 Apr 30;54:127045. doi: 10.1016/j.vaccine.2025.127045. Epub 2025 Apr 3. Vaccine. 2025. PMID: 40179522 Free article. Clinical Trial.
Host response to respiratory syncytial virus infection.
Arruvito L, Raiden S, Geffner J. Arruvito L, et al. Among authors: geffner j. Curr Opin Infect Dis. 2015 Jun;28(3):259-66. doi: 10.1097/QCO.0000000000000159. Curr Opin Infect Dis. 2015. PMID: 25887611 Review.
Neutrophils suppress γδ T-cell function.
Sabbione F, Gabelloni ML, Ernst G, Gori MS, Salamone G, Oleastro M, Trevani A, Geffner J, Jancic CC. Sabbione F, et al. Among authors: geffner j. Eur J Immunol. 2014 Mar;44(3):819-30. doi: 10.1002/eji.201343664. Epub 2013 Dec 27. Eur J Immunol. 2014. PMID: 24271816 Free article.
170 results